Stocks and Investing
Source : (remove) : NBC Chicago
RSS • JSON • XML • CSV
Stocks and Investing
Source : (remove) : NBC Chicago
RSS • JSON • XML • CSV

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -investments-as-trump-s-pharma-tariffs-loom.html
  Print publication without navigation Published in Stocks and Investing on by
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
  Tariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.


The article from NBC Chicago discusses how several pharmaceutical companies are making new investments in the U.S. amid looming tariffs on Chinese pharmaceuticals proposed by former President Donald Trump. Companies like Eli Lilly, Merck, and Pfizer are expanding their U.S. operations, with Eli Lilly investing $450 million in a new manufacturing facility in North Carolina, Merck planning a $1 billion expansion in Virginia, and Pfizer announcing a $1.8 billion investment in North Carolina. These investments are seen as a response to potential supply chain disruptions due to the proposed tariffs, which aim to reduce U.S. reliance on Chinese pharmaceuticals. The article highlights that these moves could lead to job creation and increased domestic production of critical drugs, aligning with broader efforts to bolster the U.S. pharmaceutical industry.

Read the Full NBC Chicago Article at:
[ https://www.nbcchicago.com/news/business/money-report/healthy-returns-here-are-the-drugmakers-with-new-u-s-investments-as-trumps-pharma-tariffs-loom/3734566/ ]